Mikhail Chumakov Mikhail Chumakov Mikhail Petrovich Chumakov () (November 14, 1909 – June 11, 1993) was a Soviet microbiologist and virologist most famous for conducting pivotal large-scale clinical trials that led to licensing of the Oral Polio Vaccine (OPV) developed by Albert B. Sabin. Chumakov graduated in 1931 from Moscow State University Medical School that was later transformed into I.M. Sechenov Moscow Medical Academy. In 1937 Chumakov participated in a scientific expedition to Khabarovsk region of Soviet Far East that was led by Professor . Together with his colleagues he discovered the etiology of a new transmissible neurological disease called tick-borne encephalitis
Sabin Vaccine Institute Africa, and the Americas. Sabin is currently working on multiple vaccines for humans including vaccines for Hookworm infection ("Na"-GST-1, "Na"-APR-1), Schistosomiasis ("Sm"-TSP-2), Chagas disease ("Tc"24, TSA-1), Leishmaniasis ("Ld"-NH36, PdSP15), Severe acute respiratory syndrome (SARS)/Middle East respiratory syndrome (MERS) (Pan-β-CoVax), Soil-transmitted helminthiasis (STH), and Onchocerciasis (Ov-"103", Ov-"RAL-2"). In 2006, Sabin co-founded the Global Network for Neglected Tropical Diseases in order "to raise the awareness, political will and funding necessary to control and eliminate the most common NTDs." Through its work on NTDs, Sabin hopes to reduce poverty caused by these diseases as many of them have been shown to adversely affect